Cardiovascular Diseases Clinical Trial
To assess in four large Chicago population cohorts whether young adult and middle-aged risk factor status has an impact not only on average annual Medicare costs, but also on cumulative and lifetime Medicare costs, to ages 70, 75, 80, >80, including to death, and during the last one to two years of life.
BACKGROUND:
Studies will be conducted on the cumulative lifetime Medicare costs of individuals from four
Chicago population cohorts from which prior risk factor data are available. One cohort is
from the Western Electric Company Study, with 2107 men who were 40-56 when the follow up
began in 1957. For this group a physical exam, ECG and cholesterol measures are available
along with data from a quantitative diet history conducted at that time assessing 28 days of
intake. It is not clear whether the men themselves or their wives provided this information.
Repeat measures are available, but attention is paid to their use in the analyses. Also,
information on the availability of the quantitative information at the food level is not
provided. Two cohorts are from the Peoples Gas Company Study, one with 1594 men aged 40-59
in 1958 and the second with 1609 men aged 25-39 in 1959 . From both cohorts a total of 1802
men are, based on their ages, currently Medicare eligible.The fourth cohort is the Chicago
Heart Disease Detection Association Project (CHA) based on an initial survey of 39,573 men
and women conducted in 1967-1973 on whom dietary data are not available.
DESIGN NARRATIVE:
The study assesses the relationships of CVD risk factors measured in young and middle-aged
adult men and women to Medicare utilization and charges, from Medicare enrollment to death
or attainment of age 70, 75, 80, >80, including in the last one to two years of life. The
study determines long-term relationship between earlier low-risk status vs. not-low-risk to
subsequent Medicare health care charges. Baseline low risk is all six CVD risk factors
favorable: systolic/diastolic pressure 120 mmHg/80 mmHg and no antihypertensive treatment,
serum cholesterol <200 mg/dl, not currently smoking, no ECG abnormalities, no history of
diabetes or heart attack. The study also determines the relationships between baseline
habitual eating patterns and subsequent Medicare utilization and charges. Further
statistical methods are developed for optimal analyses of health care expenditures. The
database will be extended by obtaining additional years of morbidity-mortality experience
and of Medicare charge data to the year 2002.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|